Siemens wins Scripps supply contract
Siemens Medical Systems has signed a 10-year agreement potentially worth $10 million with Scripps, a regional healthcare system in San Diego, CA. The contract stipulates that Siemens will provide Scripps with consulting services to improve its work
Siemens Medical Systems has signed a 10-year agreement potentially worth $10 million with Scripps, a regional healthcare system in San Diego, CA. The contract stipulates that Siemens will provide Scripps with consulting services to improve its work processes, along with the vendors, imaging cardiology, and oncology care equipment.
As part of the contract, Siemens will suggest ways Scripps can improve its operating and program processes and will work with Scripps to reduce costs. Siemens will serve as Scripps preferred supplier of imaging equipment, cardiac care and oncology treatment systems, patient monitoring units, data networking and communications systems, and physical plant equipment.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
